PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 280 (xsd:integer)
nif:isString
  • These results suggest that PPARĪ³ agonist DIM-C can be an excellent alternative to bladder tumors resistant to EGFR inhibition and combination efficacy might be achieved in a schedule-specific manner. http://www.src-crs.ca/en-CAhttp://www.frsq.gouv.qc.ca/en/index.shtmlIntroduction
rdf:type